Skip to main content
. Author manuscript; available in PMC: 2015 Aug 10.
Published in final edited form as: Acta Trop. 2014 Jul 19;138:78–82. doi: 10.1016/j.actatropica.2014.07.007

Table 1.

Sample details and NIE-DBS ELISA result summary.

Pre-treatment
Post-treatment
MDA 1 MDA 2 Overall pre-treatment MDA 2 (enrolled/treated at MDA1)
Number of samples 124 40 164 50
Median age in years (IQR) 5.3 (3.2–7.8) 2.3 (1.2–5.1)** 4.7 (2.3–7) 4 (2.4–5.5)
Median NIE-DBS ELISA result (IQR) 0.04 (0.01–0.14) 0.08 (0.08–0.18) 0.05 (0.02–0.15) 0.06 (0.01–0.14)
NIE-DBS positive (above cut-off 0.21) (%) 19 (15.3%) 8 (20.0%) 27 (16.5%) 6 (12.0%)
**

p = 0.0004.

MDA, mass drug administration; IQR, interquartile range.